| ABT | Activity-based therapy |
| AI | Artificial intelligence |
| BDNF | Brain-derived neurotrophic factor |
| cAMP | Cyclic adenosine monophosphate |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| CSPG | chondroitin sulphate proteoglycan |
| DREADDs | Designer receptors exclusively activatable by designer drugs |
| ECM | Extracellular matrix |
| FSC | Fetal spinal cord |
| hESC | Human embryonic stem cell |
| HLA | Human leukocyte antigen |
| iPSC | Induced pluripotent stem cell |
| MSC | Mesenchymal stem cell |
| ML | Machine learning |
| NPC | Neural progenitor cell |
| NT3 | Neurotrophin-3 |
| NSC | Neural stem cell |
| OEC | Olfactory ensheathing cell |
| OPC | Oligodendrocyte progenitor cell |
| PEDOT | poly (3,4-ethylenedioxythiophene) |
| PEG | Polyethylene glycol |
| PLGA | Poly lactic-co-glycolic acid |
| PSS | Polystyrene sulfonate |
| PSC | Pluripotent stem cell |
| SCI | Spinal cord injury |
| SpIN | Spinal interneuron |